-
1
AMD-SD: An Optical Coherence Tomography Image Dataset for wet AMD Lesions Segmentation
Published 2024-09-01“…Abstract Wet Age-related Macular Degeneration (wet AMD) is a common ophthalmic disease that significantly impacts patients’ vision. …”
Get full text
Article -
2
-
3
-
4
Pharmacotherapy for AMD: state-of-the-art
Published 2019-07-01“…<p> <i>The article discusses the evolution of the treatment for a socially important disease, age-related macular degeneration (AMD). Data on earlier and recent treatment for “wet” AMD as well as promising trends in the development of novel medications are addressed.…”
Get full text
Article -
5
-
6
-
7
Oxidative and carbonyl stress induced AMD and Codonopsis lanceolata ameliorates AMD via controlling oxidative and carbonyl stress
Published 2024-07-01Subjects: “…Age-related macular degeneration (AMD)…”
Get full text
Article -
8
The complex model of risk and progression of AMD estimation
Published 2014-07-01Subjects: “…amd…”
Get full text
Article -
9
Analysis of OCT Scanning Parameters in AMD and RVO
Published 2024-02-01“…Optical coherence tomography (OCT) is an extensively used imaging tool for disease monitoring in both age-related macular degeneration (AMD) and retinal vein occlusion (RVO). However, there is limited literature on minimum requirements of OCT settings for reliable biomarker detection. …”
Get full text
Article -
10
Real-world experience of brolucizumab in nAMD
Published 2024-01-01“…Purpose: To evaluate real-world outcomes with neovascular age-related macular degeneration (nAMD) in relation to anatomical success, visual outcomes, and safety of intravitreal brolucizumab (IVBr) injection at 1.5 years. …”
Get full text
Article -
11
THE COMPARATIVE TEACHING AMD LEARNING GRAMMATICAL CATEGORIES
Published 2011-11-01Get full text
Article -
12
Anti-VEGF Treatment Strategies for Wet AMD
Published 2012-01-01“…Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. …”
Get full text
Article -
13
Predicting Visual Acuity in Patients Treated for AMD
Published 2022-06-01“…The dataset contains 94 patients with AMD and there are 161 eyes included with more than one medical examination. …”
Get full text
Article -
14
Was gibt es Neues in der AMD-Landschaft?
Published 2023-04-01“…As society ages, the importance of age-related eye diseases such as age-related macular degeneration (AMD) increases. The intravitreal treatment of neovascular AMD (nAMD), which accounts for about 10% of all AMD cases, revolutionized the world of ophthalmology about 15 years ago. …”
Get full text
Article -
15
-
16
System analysis of factors in the pathogenesis of drusen formation in AMD
Published 2020-04-01“…Background: Age-related macular degeneration (AMD) is a major cause of visual loss in elderly individuals. …”
Get full text
Article -
17
Sodium Iodate: Rapid and Clinically Relevant Model of AMD
Published 2024-11-01“…Background: Age-related macular degeneration (AMD) is the most common cause of vision loss in people above the age of 50, affecting approximately 10% of the population worldwide and the incidence is rising. …”
Get full text
Article -
18
Gains in the current understanding of managing neovascular AMD with brolucizumab
Published 2023-11-01Get full text
Article -
19
The role of mitochondria in AMD: Current knowledge and future applications
Published 2017-01-01“…Cybrid cell lines that have identical nuclei but mitochondria from different individuals can provide a unique means for studying the relationship between mitochondria and AMD. Different approaches for protection of mitochondria have been introduced which can be considered as potential future treatments for AMD and other age- related disorders.…”
Get full text
Article -
20
Systems Biology Profiling of AMD on the Basis of Gene Expression
Published 2013-01-01“…Genetic pathways underlying the initiation and progression of age-related macular degeneration (AMD) have not been yet sufficiently revealed, and the correlations of AMD’s genotypes, phenotypes, and disease spectrum are still awaiting resolution. …”
Get full text
Article